French health authority refuses early access to donanemab France’s health authority, the Haute Autorité de santé (HAS), has rejected a request for early access to donanemab for the treatment of early Alzheime

French health authority refuses early access to donanemab
#AEScienceWatch

www.alzheimer-europe.org/news/french-...

Anavex announces withdrawal of European marketing authorisation application for blarcamesine Anavex Life Sciences has announced the withdrawal of its European marketing authorisation application (MAA) for blarcamesine for the treatment of earl

Update: Anavex announced the withdrawal of their European marketing authorisation application for blarcamesine on 25 March.
#AEScienceWatch
Read more: www.alzheimer-europe.org/news/anavex-...

Gemeinsame Bundesausschuss finds no added benefit for lecanemab in Germany On 19 February, at its plenary session in Berlin, the Gemeinsame Bundesausschuss (G-BA), Germany’s highest healthcare decision-making body representin

Gemeinsame Bundesausschuss, Germany’s highest healthcare decision-making body representing physicians, dentists, hospitals and statutory health insurers, finds no added benefit for lecanemab in Germany

#AEScienceWatch
#lecanemab

www.alzheimer-europe.org/news/gemeins...

Ongoing challenges regarding accessibility and availability of clinical trials Clinical trials are essential for advancing research in Alzheimer's disease and other dementias, yet taking part in them still remains out of reach fo

In an article in Pharmaceutical Market Europe (PME), Alzheimer Europe Project Officer Cindy Birck explains why improving access to #Alzheimers and #dementia #ClinicalTrials must become a shared European priority
#AEScienceWatch

www.alzheimer-europe.org/news/ongoing...

Art-based knowledge translation successfully integrates culturally relevant storytelling with public health outreach and education A recent research article within the journal Alzheimer and Dementia – Translational Research and Clinical Interventions describes the impact of an art

Art-based knowledge translation successfully integrates culturally relevant storytelling with public health outreach and education
#AEScienceWatch

www.alzheimer-europe.org/news/art-bas...